Naltima 50 (Naltrexone 50mg.)

What is Naltima 50 (Naltrexone 50mg.)?

Naltima 50 (Naltrexone 50mg.) is a prescription medication used as part of a comprehensive treatment plan for individuals managing opioid dependence and alcohol use disorder. It functions as an opioid antagonist, meaning it binds to opioid receptors in the brain to block the euphoric and sedative effects of opioids and alcohol. By preventing the 'high' associated with substance use, Naltima 50 helps reduce cravings and supports sustained recovery. It is not a cure but a tool to aid behavioral therapy and relapse prevention.

Key features

• Active Ingredient — Naltrexone 50mg per tablet for consistent dosing.
• Mechanism of Action — Blocks opioid and alcohol-induced euphoria at receptor sites.
• Oral Tablet Form — Easy-to-swallow, once-daily dosing for adherence.
• Non-Addictive — Does not produce dependence or withdrawal symptoms.
• Prescription-Based — Used under medical supervision as part of recovery programs.
• Stable Dosage — Standard 50mg strength for adult maintenance therapy.
• Manufactured to Standards — Produced under regulated pharmaceutical guidelines.

Who is Naltima 50 (Naltrexone 50mg.) for?

This medication is intended for adults who have completed opioid detoxification and are committed to maintaining abstinence from opioids or reducing alcohol consumption. It is best suited for patients enrolled in counseling or support programs for substance use disorders. It is not intended for individuals currently using opioids, alcohol, or those with acute hepatitis or liver failure.

How does Naltima 50 (Naltrexone 50mg.) compare?

Compared to other addiction treatment medications like methadone or buprenorphine, Naltima 50 does not activate opioid receptors and carries no risk of misuse. Unlike daily suboxone regimens, it is non-narcotic and non-sedating. When compared to standard behavioral therapy alone, it adds a pharmacological barrier to relapse. It is less invasive than implant-based naltrexone options but requires strict daily adherence. It offers a cost-effective, oral alternative to injectable extended-release naltrexone formulations.